BTC/USD Bears Eyeing 53150: Sally Ho's Technical Analysis 28 November 2021 BTC

Bitcoin (BTC/USD) remained pressured early in the Asian session as the pair traded at its lowest levels since early October following a sharp sell-off to the 53533 level.  Stops were elected below the 53835.20 area, representing the 38.2% retracement of the appreciating range from 29301.56 to 69000, and additional downside retracement levels include the 49150.78, 44466.36, 38670.39, and 37797.03 areas.  Stops are likely in place below the 53150 area, representing the 50% retracement of the appreciating range from 37300 to 69000.
Following the pair’s recent volatility, downside retracement levels and areas of potential technical support include the 53150, 52598, 49409, and 49150 levels.  Traders are observing that the 50-bar MA (4-hourly) is bearishly indicating below the 100-bar MA (4-hourly) and below the 200-bar MA (4-hourly).   Also, the 50-bar MA (hourly) is bearishly indicating below the 200-bar MA (hourly) and below the 100-bar MA (hourly).
Price activity is nearest the 50-bar MA (4-hourly) at 57382.23 and the 50-bar MA (Hourly) at 56143.68.
Technical Support is expected around 53150/ 51245.86/ 49022.22 with Stops expected below.
Technical Resistance is expected around 69000/ 69449.40/ 77565.60 with Stops expected above.  
On 4-Hourly chart, SlowK is Bearishly below SlowD while MACD is Bearishly below MACDAverage.


More hawkish than expected is good for currency;
Due to hold a press conference about the Financial Stability Report, in Wellington;
Consumer Financial Services TAIPEI, Sept 22 (Reuters) - Taiwan’s central bank said on Tuesday it had agreed to provide an extra T$100 billion ($3.44 billion) in financing for small and medium sized companies to help them cope with the impact of the coronavirus pandemic, bringing the total to T$300 billion.
From CNN's Stephanie Halasz UK Minister for the Cabinet Office Michael Gove spoke today about new measures to tackle the surge in coronavirus cases in the country.
By Sachin Ravikumar BENGALURU, Sept 22 (Reuters) - Dr Reddy’s Laboratories Ltd could begin late-stage Indian clinical trials of Russia’s potential coronavirus vaccine in the next few weeks, an executive at the Indian drugmaker said on Tuesday.
2all - Web Design